FMISO PET Study of Glioblastoma

NCT02076152 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioblastoma

Interventions

DEVICE: FMISO PET
DEVICE: MRI
DRUG: Bevacizumab
DRUG: CCNU

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]